Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07418853 · ClinicalTrials.gov registry record · NA
Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
A NA study, sponsored by Henry Ford Health System.
- Not yet
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT07418853: Clinical Trial NA study, sponsored by Henry Ford Health System.
NCT07418853 is a NA study that has not yet begun recruiting, run by Henry Ford Health System. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07418853, a NA study, has not yet begun recruiting, sponsored by Henry Ford Health System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month
Primary Outcome
Eye pressure as measured by Goldmann applanation tonometry in mmHg
Interventions
- PROCEDURE Goniotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
What is known before NCT07418853 opens enrollment
NCT07418853 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Goniotomy is the first listed.
NCT07418853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07418853 about?
NCT07418853 is a clinical study titled "Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries". The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after...
What is the current status of trial NCT07418853?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2026-07-01. Estimated completion is 2028-03-01.
What interventions are being tested in trial NCT07418853?
The interventions under investigation include: Goniotomy (PROCEDURE).
Who is sponsoring clinical trial NCT07418853?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07418853's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI